The acarbose API market is gaining importance within the pharmaceutical industry as demand for effective diabetes management continues to support the need for high-quality active pharmaceutical ingredients. Acarbose is an alpha-glucosidase inhibitor used to help control blood glucose levels, particularly in patients with type 2 diabetes. The acarbose API market size was valued at US$ 486.62...